The olive biophenols oleuropein and hydroxytyrosol selectively reduce proliferation, influence the cell cycle, and induce apoptosis in pancreatic cancer cells

International Journal of Molecular Sciences

Volumn 19, Issue 7, 2018, Pages

  Goldsmith, Chloe D ^a,b   Bond, Danielle R ^a,b,d   Jankowski, Helen ^b,d   Weidenhofer, Judith ^b,d   Stathopoulos, Costas E ^c   Roach, Paul D ^b   Scarlett, Christopher J ^a,b,d  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c UNIVERSITY OF ABERTAY DUNDEE   (United Kingdom)

^d HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

Anti cancer; Chemoprevention; HPDE; Hydroxytyrosol; MIA PaCa 2; Nutraceutical; Oleuropein; Olive; Phenolic compound

Indexed keywords

ADAMTS1 PROTEIN; CASPASE 3; CASPASE 7; EARLY GROWTH RESPONSE FACTOR 1; GEMCITABINE; HYDROXYTYROSOL; OLEUROPEIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN C FOS; PROTEIN C JUN; 3,4-DIHYDROXYPHENYLETHANOL; APOPTOSIS REGULATORY PROTEIN; IRIDOID; PHENETHYL ALCOHOL; TUMOR PROTEIN;

APOPTOSIS; APOPTOSIS ASSAY; ARTICLE; CELL CYCLE; CELL CYCLE ASSAY; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; FLOW CYTOMETRY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC50; MICROARRAY ANALYSIS; OLIVE; PANCREATIC CANCER CELL LINE; PROPIDIUM IODIDE ASSAY; PROTEIN EXPRESSION; RNA EXTRACTION; UPREGULATION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; CHEMISTRY; DRUG EFFECT; METABOLISM; OLIVE TREE; PANCREAS TUMOR; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CELL CYCLE; CELL LINE, TUMOR; HUMANS; IRIDOIDS; NEOPLASM PROTEINS; OLEA; PANCREATIC NEOPLASMS; PHENYLETHYL ALCOHOL;

EID: 85049560127     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms19071937     Document Type: Article

References (56)

1. Trichopoulou, A.; Lagiou, P.; Kuper, H.; Trichopoulos, D. Cancer and Mediterranean dietary traditions. Cancer Epidemiol. Biomarkers Prev. 2000, 9, 869–873. [PubMed]
2. Fortes, C.; Forastiere, F.; Farchi, S.; Mallone, S.; Trequattrinni, T.; Anatra, F.; Schmid, G.; Perucci, C.A. The protective effect of the Mediterranean diet on lung cancer. Nutr. Cancer 2003, 46, 30–37. [CrossRef] [PubMed]
3. Kapiszewska, M.; Soltys, E.; Visioli, F.; Cierniak, A.; Zajac, G. The protective ability of the Mediterranean plant extracts against the oxidative DNA damage. The role of the radical oxygen species and the polyphenol content. J. Physiol. Pharmacol. 2005, 56 (Suppl. 1), 183–197. [PubMed]
4. Bosetti, C.; Turati, F.; Dal Pont, A.; Ferraroni, M.; Polesel, J.; Negri, E.; Serraino, D.; Talamini, R.; La Vecchia, C.; Zeegers, M.P. The role of Mediterranean diet on the risk of pancreatic cancer. Br. J. Cancer 2013, 109, 1360–1366. [CrossRef] [PubMed]
5. Serra-Majem, L.; Ngo de la Cruz, J.; Ribas, L.; Tur, J.A. Olive oil and the Mediterranean diet: Beyond the rhetoric. Eur. J. Clin. Nutr. 2003, 57 (Suppl. 1), S2–S7. [CrossRef] [PubMed]
6. Burns, C. The Australian Olive Industry Research, Development and Extension Plan 2010–2015; RIRDC, Ed.; RIRDC: Canberra, Australia, 2010; pp. 1–76.
7. Goldsmith, C.D.; Stathopoulos, C.E.; Golding, J.B.; Roach, P.D. Fate of phenolic compounds during olive oil production with the traditional press method. Int. Food Res. J. 2014, 21, 101–109.
8. Obied, H.K.; Allen, M.S.; Bedgood, D.R., Jr.; Prenzler, P.D.; Robards, K. Investigation of Australian olive mill waste for recovery of biophenols. J. Agric. Food Chem. 2005, 53, 9911–9920. [CrossRef] [PubMed]
9. Seabra, R.M.; Vinha, A.F.; Ferreres, F.; Silva, B.M.; Valentao, P.; Goncalves, A.; Pereira, J.A.; Oliveira, M.B.; Andrade, P.B. Phenolic profiles of Portuguese olive fruits (Olea europaea L.): Influences of cultivar and geographical origin. Food Chem. 2005, 89, 561–568. [CrossRef]
10. Goldsmith, C.; Vuong, Q.; Sadeqzadeh, E.; Stathopoulos, C.; Roach, P.; Scarlett, C. Phytochemical Properties and Anti-Proliferative Activity of Olea europaea L. Leaf Extracts against Pancreatic Cancer Cells. Molecules 2015, 20, 12992–13004. [CrossRef] [PubMed]
11. Goulas, V.; Exarchou, V.; Troganis, A.N.; Psomiadou, E.; Fotsis, T.; Briasoulis, E.; Gerothanassis, I.P. Phytochemicals in olive-leaf extracts and their antiproliferative activity against cancer and endothelial cells. Mol. Nutr. Food Res. 2009, 53, 600–608. [CrossRef] [PubMed]
12. Lee, O.-H.; Lee, B.-Y.; Lee, J.; Lee, H.-B.; Son, J.-Y.; Park, C.-S.; Shetty, K.; Kim, Y.-C. Assessment of phenolics-enriched extract and fractions of olive leaves and their antioxidant activities. Bioresour. Technol. 2009, 100, 6107–6113. [CrossRef] [PubMed]
13. Gomez Caravaca, A.M.; Carrasco Pancorbo, A.; Canabate Diaz, B.; Segura Carretero, A.; Fernandez Gutierrez, A. Electrophoretic identification and quantitation of compounds in the polyphenolic fraction of extra-virgin olive oil. Electrophoresis 2005, 26, 3538–3551. [CrossRef] [PubMed]
14. Carrera-González, M.P.; Ramírez-Expósito, M.J.; Mayas, M.D.; Martínez-Martos, J.M. Protective role of oleuropein and its metabolite hydroxytyrosol on cancer. Trends Food Sci. Technol. 2013, 31, 92–99. [CrossRef]
15. Klen, T.J.; Vodopivec, B.M. The fate of olive fruit phenols during commercial olive oil processing: Traditional press versus continuous two-and three-phase centrifuge. LWT Food Sci. Technol. 2012, 49, 267–274. [CrossRef]
16. Hassan, Z.K.; Elamin, M.H.; Omer, S.A.; Daghestani, M.H.; Al-Olayan, E.S.; Elobeid, M.A.; Virk, P. Oleuropein induces apoptosis via the p53 pathway in breast cancer cells. Asian Pac. J. Cancer Prev. 2013, 14, 6739–6742. [CrossRef]
17. Cardeno, A.; Sanchez-Hidalgo, M.; Rosillo, M.A.; de la Lastra, C.A. Oleuropein, a secoiridoid derived from olive tree, inhibits the proliferation of human colorectal cancer cell through downregulation of HIF-1α. Nutr. Cancer 2013, 65, 147–156. [CrossRef] [PubMed]
18. Acquaviva, R.; Di Giacomo, C.; Sorrenti, V.; Galvano, F.; Santangelo, R.; Cardile, V.; Gangia, S.; D’Orazio, N.; Abraham, N.G.; Vanella, L. Antiproliferative effect of oleuropein in prostate cell lines. Int. J. Oncol. 2012, 41, 31–38. [CrossRef] [PubMed]
19. Yan, C.M.; Chai, E.Q.; Cai, H.Y.; Miao, G.Y.; Ma, W. Oleuropein induces apoptosis via activation of caspases and suppression of phosphatidylinositol 3-kinase/protein kinase B pathway in HepG2 human hepatoma cell line. Mol. Med. Rep. 2015, 11, 4617–4624. [CrossRef] [PubMed]
20. Fabiani, R.; De Bartolomeo, A.; Rosignoli, P.; Servili, M.; Montedoro, G.F.; Morozzi, G. Cancer chemoprevention by hydroxytyrosol isolated from virgin olive oil through G1 cell cycle arrest and apoptosis. Eur. J. Cancer Prev. 2002, 11, 351–358. [CrossRef] [PubMed]
21. Zrelli, H.; Matsuoka, M.; Kitazaki, S.; Araki, M.; Kusunoki, M.; Zarrouk, M.; Miyazaki, H. Hydroxytyrosol induces proliferation and cytoprotection against oxidative injury in vascular endothelial cells: Role of Nrf2 activation and HO-1 induction. J. Agric. Food Chem. 2011, 59, 4473–4482. [CrossRef] [PubMed]
22. Elamin, M.H.; Elmahi, A.B.; Daghestani, M.H.; Al-Olayan, E.M.; Al-Ajmi, R.A.; Alkhuriji, A.F.; Hamed, S.S.; Elkhadragy, M.F. Synergistic Anti-Breast-Cancer Effects of Combined Treatment With Oleuropein and Doxorubicin In Vivo. Altern. Ther. Health Med. 2017, 23, 7.
23. Samara, P.; Christoforidou, N.; Lemus, C.; Argyropoulou, A.; Ioannou, K.; Vougogiannopoulou, K.; Aligiannis, N.; Paronis, E.; Gaboriaud-Kolar, N.; Tsitsilonis, O.; et al. New semi-synthetic analogs of oleuropein show improved anticancer activity in vitro and in vivo. Eur. J. Med. Chem. 2017, 137, 11–29. [CrossRef] [PubMed]
24. Kimura, Y.; Sumiyoshi, M. Olive leaf extract and its main component oleuropein prevent chronic ultraviolet B radiation-induced skin damage and carcinogenesis in hairless mice. J. Nutr. 2009, 139, 2079–2086. [CrossRef] [PubMed]
25. Silva, S.; Sepodes, B.; Rocha, J.; Direito, R.; Fernandes, A.; Brites, D.; Freitas, M.; Fernandes, E.; Bronze, M.R.; Figueira, M.E. Protective effects of hydroxytyrosol-supplemented refined olive oil in animal models of acute inflammation and rheumatoid arthritis. J. Nutr. Biochem. 2015, 26, 360–368. [CrossRef] [PubMed]
26. Li, S.; Han, Z.; Ma, Y.; Song, R.; Pei, T.; Zheng, T.; Wang, J.; Xu, D.; Fang, X.; Jiang, H.; et al. Hydroxytyrosol inhibits cholangiocarcinoma tumor growth: An in vivo and in vitro study. Oncol. Rep. 2014, 31, 145–152. [CrossRef] [PubMed]
27. Zhao, B.; Ma, Y.; Xu, Z.; Wang, J.; Wang, F.; Wang, D.; Pan, S.; Wu, Y.; Pan, H.; Xu, D.; et al. Hydroxytyrosol, a natural molecule from olive oil, suppresses the growth of human hepatocellular carcinoma cells via inactivating AKT and nuclear factor-kappa B pathways. Cancer Lett. 2014, 347, 79–87. [CrossRef] [PubMed]
28. Vincent, A.; Herman, J.; Schulick, R.; Hruban, R.H.; Goggins, M. Pancreatic cancer. Lancet 2011, 378, 607–620. [CrossRef]
29. Bosetti, C.; Bravi, F.; Turati, F.; Edefonti, V.; Polesel, J.; Decarli, A.; Negri, E.; Talamini, R.; Franceschi, S.; La Vecchia, C.; Zeegers, M.P. Nutrient-based dietary patterns and pancreatic cancer risk. Ann. Epidemiol. 2013, 23, 124–128. [CrossRef] [PubMed]
30. Mandavilli, B.S.; Yan, M.; Clarke, S. Cell-Based High Content Analysis of Cell Proliferation and Apoptosis. Methods Mol. Biol. 2018, 1683, 47–57. [CrossRef] [PubMed]
31. Thandapani, P.; Aifantis, I. Apoptosis, Up the Ante. Cancer Cell 2017, 32, 402–403. [CrossRef] [PubMed]
32. Wang, C.; Husain, K.; Zhang, A.; Centeno, B.A.; Chen, D.-T.; Tong, Z.; Sebti, S.M.; Malafa, M.P. EGR-1/Bax pathway plays a role in vitamin E δ-tocotrienol-induced apoptosis in pancreatic cancer cells. J. Nutr. Biochem. 2015, 26, 797–807. [CrossRef] [PubMed]
33. Ren, X.; Zhao, W.; Du, Y.; Zhang, T.; You, L.; Zhao, Y. Activator protein 1 promotes gemcitabine-induced apoptosis in pancreatic cancer by upregulating its downstream target Bim. Oncol. Lett. 2016, 12, 4732–4738. [CrossRef] [PubMed]
34. De Arao Tan, I.; Ricciardelli, C.; Russell, D.L. The metalloproteinase ADAMTS1: A comprehensive review of its role in tumorigenic and metastatic pathways. Int. J. Cancer 2013, 133, 2263–2276. [CrossRef] [PubMed]
35. Granados-Principal, S.; Quiles, J.L.; Ramirez-Tortosa, C.L.; Sanchez-Rovira, P.; Ramirez-Tortosa, M.C. Hydroxytyrosol: From laboratory investigations to future clinical trials. Nutr. Rev. 2010, 68, 191–206. [CrossRef] [PubMed]
36. Omar, S.H. Oleuropein in Olive and its Pharmacological Effects. Sci. Pharm. 2010, 78, 133–154. [CrossRef] [PubMed]
37. Chimento, A.; Casaburi, I.; Rosano, C.; Avena, P.; De Luca, A.; Campana, C.; Martire, E.; Santolla, M.F.; Maggiolini, M.; Pezzi, V.; et al. Oleuropein and hydroxytyrosol activate GPER/GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells. Mol. Nutr. Food Res. 2013, 58, 478–489. [CrossRef] [PubMed]
38. Angelino, D.; Gennari, L.; Blasa, M.; Selvaggini, R.; Urbani, S.; Esposto, S.; Servili, M.; Ninfali, P. Chemical and cellular antioxidant activity of phytochemicals purified from olive mill waste waters. J. Agric. Food Chem. 2011, 59, 2011–2018. [CrossRef] [PubMed]
39. Secme, M.; Eroglu, C.; Dodurga, Y.; Bagci, G. Investigation of anticancer mechanism of oleuropein via cell cycle and apoptotic pathways in SH-SY5Y neuroblastoma cells. Gene 2016, 585, 93–99. [CrossRef] [PubMed]
40. Zubair, H.; Bhardwaj, A.; Ahmad, A.; Srivastava, S.K.; Khan, M.A.; Patel, G.K.; Singh, S.; Singh, A.P. Hydroxytyrosol Induces Apoptosis and Cell Cycle Arrest and Suppresses Multiple Oncogenic Signaling Pathways in Prostate Cancer Cells. Nutr. Cancer 2017, 69, 932–942. [CrossRef] [PubMed]
41. Baudino, T.A. Targeted Cancer Therapy: The Next Generation of Cancer Treatment. Curr. Drug Discov. Technol. 2015, 12, 3–20. [CrossRef] [PubMed]
42. Ganesan, V.; Colombini, M. Regulation of ceramide channels by Bcl-2 family proteins. FEBS Lett. 2010, 584, 2128–2134. [CrossRef] [PubMed]
43. Cao, S.; Zhu, X.; Du, L. P38 MAP kinase is involved in oleuropein-induced apoptosis in A549 cells by a mitochondrial apoptotic cascade. Biomed. Pharmacother. 2017, 95, 1425–1435. [CrossRef] [PubMed]
44. Hassan, Z.K.; Elamin, M.H.; Daghestani, M.H.; Omer, S.A.; Al-Olayan, E.M.; Elobeid, M.A.; Virk, P.; Mohammed, O.B. Oleuropein induces anti-metastatic effects in breast cancer. Asian Pac. J. Cancer Prev. APJCP 2012, 13, 4555–4559. [CrossRef] [PubMed]
45. Chinenov, Y.; Kerppola, T.K. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 2001, 20, 2438–2452. [CrossRef] [PubMed]
46. Shaulian, E. AP-1—The Jun proteins: Oncogenes or tumor suppressors in disguise? Cell. Signal. 2010, 22, 894–899. [CrossRef] [PubMed]
47. Ham, J.; Babij, C.; Whitfield, J.; Pfarr, C.M.; Lallemand, D.; Yaniv, M.; Rubin, L.L. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death. Neuron 1995, 14, 927–939. [CrossRef]
48. Estus, S.; Zaks, W.J.; Freeman, R.S.; Gruda, M.; Bravo, R.; Johnson, E.M., Jr. Altered gene expression in neurons during programmed cell death: Identification of c-jun as necessary for neuronal apoptosis. J. Cell Biol. 1994, 127, 1717–1727. [CrossRef] [PubMed]
49. Oben, K.Z.; Alhakeem, S.S.; McKenna, M.K.; Brandon, J.A.; Mani, R.; Noothi, S.K.; Jinpeng, L.; Akunuru, S.; Dhar, S.K.; Singh, I.P.; et al. Oxidative stress-induced JNK/AP-1 signaling is a major pathway involved in selective apoptosis of myelodysplastic syndrome cells by Withaferin-A. Oncotarget 2017, 8, 77436–77452. [CrossRef] [PubMed]
50. Kalaiselvan, I.; Samuthirapandi, M.; Govindaraju, A.; Sheeja Malar, D.; Kasi, P.D. Olive oil and its phenolic compounds (hydroxytyrosol and tyrosol) ameliorated TCDD-induced heptotoxicity in rats via inhibition of oxidative stress and apoptosis. Pharm. Biol. 2016, 54, 338–346. [CrossRef] [PubMed]
51. Zamani, M.; Hassanshahi, J.; Soleimani, M.; Zamani, F. Neuroprotective effect of olive oil in the hippocampus CA1 neurons following ischemia: Reperfusion in mice. J. Neurosci. Rural Pract. 2013, 4, 164–170. [CrossRef] [PubMed]
52. Geyikoglu, F.; Emir, M.; Colak, S.; Koc, K.; Turkez, H.; Bakir, M.; Hosseinigouzdagani, M.; Cerig, S.; Keles, O.N.; Ozek, N.S. Effect of oleuropein against chemotherapy drug-induced histological changes, oxidative stress, and DNA damages in rat kidney injury. J. Food Drug Anal. 2017, 25, 447–459. [CrossRef] [PubMed]
53. Kuno, K.; Okada, Y.; Kawashima, H.; Nakamura, H.; Miyasaka, M.; Ohno, H.; Matsushima, K. ADAMTS-1 cleaves a cartilage proteoglycan, aggrecan. FEBS Lett. 2000, 478, 241–245. [CrossRef]
54. Gustavsson, H.; Wang, W.; Jennbacken, K.; Welen, K.; Damber, J.E. ADAMTS1, a putative anti-angiogenic factor, is decreased in human prostate cancer. BJU Int. 2009, 104, 1786–1790. [CrossRef] [PubMed]
55. Lind, G.E.; Kleivi, K.; Meling, G.I.; Teixeira, M.R.; Thiis-Evensen, E.; Rognum, T.O.; Lothe, R.A. ADAMTS1, CRABP1, and NR3C1 identified as epigenetically deregulated genes in colorectal tumorigenesis. Cell. Oncol. 2006, 28, 259–272. [CrossRef] [PubMed]
56. Choi, J.E.; Kim, D.S.; Kim, E.J.; Chae, M.H.; Cha, S.I.; Kim, C.H.; Jheon, S.; Jung, T.H.; Park, J.Y. Aberrant methylation of ADAMTS1 in non-small cell lung cancer. Cancer Genet. Cytogenet. 2008, 187, 80–84. [CrossRef] [PubMed]